Serum expression of IL-1b, IL-6, IP-10, PDGF-BB, and RANTES was found to be significantly different in melanoma vs. controls (Table 2), reinforced by a much larger patient cohort, since previous observations were carried out on much smaller patient cohorts [34,35]. Here, IL6 is linked to melanoma.